Production of high-complexity frameshift neoantigen peptide microarrays-Reference-Cited by-同舟云学术

Production of high-complexity frameshift neoantigen peptide microarrays

Published:2020 Issue:50 Volume:10 Page:29675-29681
ISSN:2046-2069
Container-title:RSC Advances
language:en
Short-container-title:RSC Adv.

Author:

Shen Luhui¹²³⁴⁵^ORCID,Zhao Zhan-Gong¹²³⁴⁵^ORCID,Lainson John C.¹²³⁴⁵,Brown Justin R.⁶⁴⁵^ORCID,Sykes Kathryn F.⁶⁴⁵^ORCID,Johnston Stephen Albert¹²³⁴⁵,Diehnelt Chris W.¹²³⁴⁵^ORCID

Affiliation:

1. Center for Innovations in Medicine

2. Biodesign Institute

3. Arizona State University

4. Tempe

5. USA

6. Calviri, Inc.

Abstract

An in situ synthesized peptide microarray of frameshift neoantigens was developed for the measurement of >400 000 antibody-antigen interactions in a single assay.

Funder

Arizona State University

Publisher

Royal Society of Chemistry (RSC)

Subject

General Chemical Engineering,General Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2020/RA/D0RA05267A

Reference37 articles.

1. Kinome and phosphoproteome of high-grade meningiomas reveal AKAP12 as a central regulator of aggressiveness and its possible role in progression

2. Combinatorial Synthesis of Macromolecular Arrays by Microchannel Cantilever Spotting (µCS)

3. Miniaturized and Automated Synthesis of Biomolecules—Overview and Perspectives

4. A Trifunctional Linker for Purified 3D Assembled Peptide Structure Arrays

5. Bayesian Analysis of MicroScale Thermophoresis Data to Quantify Affinity of Protein:Protein Interactions with Human Survivin

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Peptide Microarray Platform Approach for Discovery of Immunodominant Antibody Epitopes;Analytical Chemistry;2024-08-29

2. Predicting response and toxicity to immune checkpoint inhibitors in lung cancer using antibodies to frameshift neoantigens;Journal of Translational Medicine;2023-05-22

3. Vaccines for immunoprevention of DNA mismatch repair deficient cancers;Journal for ImmunoTherapy of Cancer;2022-06